课题基金 / 基金详情

Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood

Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood
血液中新型 Slicer 依赖性 miRNA 通路的分子和遗传分析
批准号:
9219500
负责人:
Michael Kharas
金额:
$69.86万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-10 至 2021-01-31

项目摘要

项目成果

Michael Kharas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT Molecular and genetic analysis of novel Slicer-dependent miRNA pathways in blood Most conserved microRNAs (miRNAs) are generated by a biogenesis pathway that deposits them into an Argonaute effector, guiding them to broad regulatory target networks. Amongst the cohort of four mammalian Argonautes, only Ago2 has catalytic ability to cleave transcripts, an enzymatic activity known as "Slicing" that underlies experimental RNA interference. Nevertheless, the endogenous biological usage of mammalian Slicing remains largely mysterious. Our previous and ongoing studies provide the unexpected perspective of multiple Slicing-dependent biogenesis strategies that generate both Dicer-independent and Dicer-dependent erythroid miRNAs. These data strongly support our hypothesis that a dominant usage of Ago2 catalysis is to generate specific conserved miRNAs in the blood system. Our extensive preliminary data are the basis of (1) a series of biochemical and genomic experiments to elucidate a novel Slicing-dependent miRNA biogenesis mechanism, (2) genetic studies of novel knockout animals of erythroid, Slicing-dependent miRNAs in normal development, blood homeostasis and leukemia, and (3) molecular genetic analyses that seek to connect dysregulated processes in Ago2-catalytically defective blood system to specific Slicing- dependent miRNAs. These studies will bring new insights on post-transcriptional control of erythroid development, homeostasis, and blood cancer, as well as pinpoint the functional basis of mammalian RNAi to the generation of erythroid-specific miRNAs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models
Characterizing MSI2 in leukemia
Characterizing the MSI2 network in leukemia
海外基金